Showing results (3351-3360 of 5,673) with videos related to
Sort By:
Pageof 568
Lupus|December 20, 2007
Clinical and immunological manifestations in 151 SLE patients living in DubaiJ AlSaleh, V Jassim, M ElSayed, et al.Lupus|February 6, 2008
Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damageC Boström, B Dupré, P Tengvar, et al.Lupus|February 27, 2014
The importance of implementing proper selection of excipients in lupus clinical trialsS Muller, D J WallaceLupus|February 19, 2014
Association of extended interleukin-10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosusH Schotte, P Willeke, H Becker, et al.Lupus|January 31, 2017
Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional studyA Checa, H Idborg, A Zandian, et al.Lupus|January 26, 2017
Belimumab for the treatment of recalcitrant cutaneous lupusP Vashisht, K Borghoff, J R O'Dell, et al.Lupus|March 29, 2019
A case with good response to belimumab for lupus nephritis complicated by IgG4-related diseaseM Yamamoto, S Aochi, C Suzuki, et al.Lupus|March 16, 2019
Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritisEmd Smith, E Al-Abadi, K Armon, et al.Lupus|October 20, 2018
Collagen triple helix repeat containing-1: a novel biomarker associated with disease activity in Systemic lupus erythematosusQ Wu, Q Yang, H SunLupus|March 7, 2014
Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritisY Nozaki, K Kinoshita, T Yano, et al.Pageof 568